/

Società

Hi

Non verificato

HistoSonics

Di cosa scriviamo

Medicina - VarieMultimedialitàOncologiaSaluteSanità

17 comunicati stampa

Guarda tutti i comunicati

18/05/2026

HistoSonics Receives Landmark TFDA Approval in Taiwan, Accelerating Global Expansion

Fonte

Emittente

1.00

0

11/05/2026

HistoSonics Moves to Advance Additional Histotripsy Applications Announcing FDA Submission for Kidney Tumors

Fonte

Emittente

1.00

0

30/03/2026

HistoSonics Treats First Patients Evaluating the Edison® Histotripsy System for the Treatment of Benign Prostatic Hyperplasia (BPH)

Fonte

Emittente

1.00

0

22/10/2025

HistoSonics Expands Insurance Coverage for Non-Invasive Liver Tumor Treatment to 45.4 Million Elevance Health Members

Fonte

Emittente

1.00

0

07/08/2025

Multimedialità

Terza età

Sanità

Medicina nucleare

Scienza

Oncologia

Software

Attrezzature medico-sanitarie

Hardware informatico

Vetrine/Shopping

Tecnica

Medicina - Varie

Igiene alimentare

Biotecnologia

Salute

Mercato azionario

HistoSonics Announces $2.25B Acquisition by Consortium of Top-Tier Investors

Fonte

Emittente

1.00

0

14/07/2025

HistoSonics Expands Insurance Coverage for Non-Invasive Liver Tumor Treatment to 7 Million Blue Cross Blue Shield Highmark Members

Fonte

Emittente

1.00

0

10/06/2025

Multimedialità

Salute

Vetrine/Shopping

Medicina nucleare

Medicina - Varie

Associazioni/Professionisti

Oncologia

Scienza

Attrezzature medico-sanitarie

Sanità

Terza età

Industria

HistoSonics and Cambridge University Unveil Europe’s First Edison™ Histotripsy System Powered by Li Ka Shing Foundation Gift

Fonte

Emittente

1.00

0

06/06/2025

HistoSonics Completes Enrollment in #HOPE4KIDNEY Trial Evaluating Non-Invasive Histotripsy to Treat Kidney Tumors

Fonte

Emittente

1.00

0

29/05/2025

HistoSonics’ Edison Histotripsy System Gains Great Britain Early Market Access Under Unmet Clinical Needs Authorisation

Fonte

Emittente

1.00

0

12/05/2025

HistoSonics Secures First Major Insurance Coverage for Non-Invasive Histotripsy Treatment for Liver Tumors With Blue Cross Blue Shield of Michigan

Fonte

Emittente

1.00

0

Seguaci

0

Compatibilità

0